285 related articles for article (PubMed ID: 19410025)
1. Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organization for these secreted proteins.
Villeneuve J; Block A; Le Bousse-Kerdilès MC; Lepreux S; Nurden P; Ripoche J; Nurden AT
Exp Hematol; 2009 Jul; 37(7):849-56. PubMed ID: 19410025
[TBL] [Abstract][Full Text] [Related]
2. Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis.
Böker KH; Pehle B; Steinmetz C; Breitenstein K; Bahr M; Lichtinghagen R
Hepatogastroenterology; 2000; 47(33):812-9. PubMed ID: 10919037
[TBL] [Abstract][Full Text] [Related]
3. Analysis of alpha2-adrenergic receptors and effect of brimonidine on matrix metalloproteinases and their inhibitors in human ciliary body.
Ooi YH; Oh DJ; Rhee DJ
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4237-43. PubMed ID: 19324857
[TBL] [Abstract][Full Text] [Related]
4. Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets.
Harrison P; Wilbourn B; Debili N; Vainchenker W; Breton-Gorius J; Lawrie AS; Masse JM; Savidge GF; Cramer EM
J Clin Invest; 1989 Oct; 84(4):1320-4. PubMed ID: 2677051
[TBL] [Abstract][Full Text] [Related]
5. Metalloproteinases and their inhibitors are markers of plaque instability.
Sapienza P; di Marzo L; Borrelli V; Sterpetti AV; Mingoli A; Cresti S; Cavallaro A
Surgery; 2005 Mar; 137(3):355-63. PubMed ID: 15746792
[TBL] [Abstract][Full Text] [Related]
6. P-selectin mRNA is expressed at a later phase of megakaryocyte maturation than mRNAs for von Willebrand factor and glycoprotein Ib-alpha.
Schick PK; Konkle BA; He X; Thornton RD
J Lab Clin Med; 1993 May; 121(5):714-21. PubMed ID: 7683032
[TBL] [Abstract][Full Text] [Related]
7. Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets.
Radomski A; Jurasz P; Sanders EJ; Overall CM; Bigg HF; Edwards DR; Radomski MW
Br J Pharmacol; 2002 Dec; 137(8):1330-8. PubMed ID: 12466243
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural localization of platelet factor 4 in rat megakaryocytes and platelets by gold-labeled antibody detection.
Hegyi E; Nakeff A
Exp Hematol; 1989 Mar; 17(3):223-8. PubMed ID: 2917621
[TBL] [Abstract][Full Text] [Related]
9. [Gray platelet syndrome, an example of myelofibrosis of megakaryocytic origin].
Caen JP; Cramer EM; Rendu F; Bryckaert M; Dupuy E; Levy-Toledano S
Bull Acad Natl Med; 1991 Oct; 175(7):1145-52; discussion 1152-3. PubMed ID: 1809489
[TBL] [Abstract][Full Text] [Related]
10. Evidence of a colocalisation of osteoprotegerin (OPG) with von Willebrand factor (VWF) in platelets and megakaryocytes alpha granules. Studies from normal and grey platelets.
Chollet ME; Brouland JP; Bal dit Sollier C; Bauduer F; Drouet L; Bellucci S
Br J Haematol; 2010 Mar; 148(5):805-7. PubMed ID: 19958354
[No Abstract] [Full Text] [Related]
11. Factor-V expression in platelets from human megakaryocytic culture.
Giampaolo A; Vulcano F; Macioce G; Mattia G; Barca A; Milazzo L; Ciccarelli C; Hassan HJ
Br J Haematol; 2005 Jan; 128(1):108-11. PubMed ID: 15606556
[TBL] [Abstract][Full Text] [Related]
12. Gray platelet syndrome. Dissociation between abnormal sorting in megakaryocyte alpha-granules and normal sorting in Weibel-Palade bodies of endothelial cells.
Gebrane-Younès J; Cramer EM; Orcel L; Caen JP
J Clin Invest; 1993 Dec; 92(6):3023-8. PubMed ID: 7504696
[TBL] [Abstract][Full Text] [Related]
13. Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome.
Larocca LM; Heller PG; Podda G; Pujol-Moix N; Glembotsky AC; Pecci A; Alberelli MA; Balduini CL; Landolfi R; Cattaneo M; De Candia E
Platelets; 2015; 26(8):751-7. PubMed ID: 25806575
[TBL] [Abstract][Full Text] [Related]
14. Localization and characterization of a novel secreted protein SCUBE1 in human platelets.
Tu CF; Su YH; Huang YN; Tsai MT; Li LT; Chen YL; Cheng CJ; Dai DF; Yang RB
Cardiovasc Res; 2006 Aug; 71(3):486-95. PubMed ID: 16753137
[TBL] [Abstract][Full Text] [Related]
15. Packaging functionally important plasma proteins into the α-granules of human-induced pluripotent stem cell-derived megakaryocytes.
Zhang N; Newman PJ
J Tissue Eng Regen Med; 2019 Feb; 13(2):244-252. PubMed ID: 30556311
[TBL] [Abstract][Full Text] [Related]
16. Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events.
Cecchetti L; Tolley ND; Michetti N; Bury L; Weyrich AS; Gresele P
Blood; 2011 Aug; 118(7):1903-11. PubMed ID: 21628401
[TBL] [Abstract][Full Text] [Related]
17. Phosphotyrosine proteins in platelets from patients with storage pool disease: direct relation between granule defects and defective signal transduction.
Arderiu G; Díaz-Ricart M; Domenech P; Escolar G; Ordinas A; Pujol-Moix N
Haematologica; 2002 Jun; 87(6):629-36. PubMed ID: 12031920
[TBL] [Abstract][Full Text] [Related]
18. Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes.
Cramer EM; Vainchenker W; Vinci G; Guichard J; Breton-Gorius J
Blood; 1985 Dec; 66(6):1309-16. PubMed ID: 3877532
[TBL] [Abstract][Full Text] [Related]
19. Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors.
Breton-Gorius J; Vainchenker W; Nurden A; Levy-Toledano S; Caen J
Am J Pathol; 1981 Jan; 102(1):10-9. PubMed ID: 7468753
[TBL] [Abstract][Full Text] [Related]
20. Platelets contribute to circulating levels of bone sialoprotein in human.
Chenu C; Delmas PD
J Bone Miner Res; 1992 Jan; 7(1):47-54. PubMed ID: 1549958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
